Evolent Health, American Oncology Network Partner to Streamline Cancer Care

Evolent Health Inc. (NYSE:EVH) is one of the best NYSE penny stocks to invest in right now. On November 6, Evolent Health and American Oncology Network announced a new national partnership. The initiative unveils an innovative model designed to provide high-quality, more affordable, and connected cancer care while eliminating the prior authorization burden for adherent providers. The model is expected to roll out in select markets in the year ahead.

American Oncology Network’s Chief Medical Officer, Dr. Stephen Divers, stated that this goes beyond common strategies like shifting to biosimilars to tackle major drivers of quality and cost in cancer care, which often burden community oncology practices.

To accelerate the time to treatment, it also eliminates prior authorization: providers who demonstrate consistent adherence to high-quality treatment pathways will be gold-carded, which means that they will no longer be required to seek authorization from payers for most tests and treatments.

Evolent Health Inc. (NYSE:EVH) provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the US. The company offers an integrated platform for health plan administration and value-based business infrastructure.

While we acknowledge the potential of EVH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.